Book Value per Share: 10x Genomics Inc (TXG)

Graphic logo of 10x (TXG)

The asset value of 10x Genomics, Inc. (TXG) tracked on this chart is currently at 6.31. Management effectively protects patents and minimizes the influence of majority shareholders through the capital structure. The company generates stable income from the sale of cell analysis equipment and ancillary reagents. The continuity of these processes is ensured by the modernization of automated facilities, where equipment operates at maximum efficiency.

10x Genomics Inc (TXG) Equity per Share: for the period 07/04/2022 - 10/27/2026

TXG (10xgenomics.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price 10x Genomics Corp|TXG - Analyst Target Range
- market capitalization data:
Market Capitalization 10x Genomics, Inc.|TXG - Business Value
- book capitalization data:
Net Assets per Single Share 10x Genomics|TXG - Accounting Capitalization|Market Capitalization to Book Value Ratio 10xgenomics.com|TXG - Company Total Assets
- debt and liquidity data:
Total Debt to Capital 10x Genomics, Inc.|TXG - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio 10x Genomics|TXG - Company Aggregate Debt|Debt to Book Value 10x Genomics, Inc.
Initial company analysis:TXG 10x Genomics Corp
Original product of 10x Genomics Inc

10x Genomics, Inc. (TXG) dominates the single-cell analysis equipment and spatial biology segment. The book value per share determines the portion of net assets available to the owner of a single security after all liabilities are settled. Investors utilize this metric to assess the actual capital density of the business. The BVPS trend allows for the tracking of financial stability between reports, which minimizes the risks of sudden capital impairment.

Competitors of 10x Genomics, Inc. (TXG)

Book Value per Share TEM|QGEN - Book Value of One Share|Book Value per Share Ionis Pharmaceuticals|RGEN (repligen.com) - Equity per Share|Net Assets per Single Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRISPR Therapeutics Inc|Book Value per Share WGS|Book Value per Share Ultragenyx Corp (RARE)|Book Value per Share Beam Therapeutics Inc. (BEAM)|SRPT - Book Price of a Share|Twist Bioscience, Inc. (TWST) - Accounting Value per Share|Intellia Therapeutics Inc (NTLA) - Equity per Share|Accounting Value per Share Stoke STOK|BioLife (BLFS) - Accounting Value of a Share|Wave Life Sciences - Book Value per Share|Book Value of One Share mazetx.com|Sionna Therapeutics - Book Value per Share|Net Asset Value per Share PRME (Prime Medicine Inc)|TSHA - Net Assets per Single Share|uniQure Pharma - Equity per Share|MGTX (MeiraGTx Holdings plc) - Net Assets per Single Share|RGNX: Net Asset Value per Share|SLDB (Solid Biosciences) - Net Assets per Single Share|Ocugen Inc (OCGN) - Accounting Value per Share|PACB: Book Value per Share|Net Assets per Share Benitec Corp|Book Value per Share DSGN (Design Therapeutics)|Accounting Value per Share RCKT (rocketpharma.com)|Net Assets per Single Share FDMT|LXEO - Net Assets per Share|Accounting Value per Share Korro Bio, Inc (KRRO)|EDIT - Accounting Value of a Share|Silence Therapeutics - Book Value per Share|PRQR (ProQR Therapeutics) - Net Assets per Share|Net Assets per Single Share Codexis Inc (CDXS)|Equity per Share Sangamo Therapeutics Inc.|Book Value per Share NAUT (Nautilus Biotechnology)|Accounting Value per Share Metagenomi Therapeutics MGX|Accounting Value per Share DTIL|GBIO - Net Assets per Share|Accounting Value per Share Boundless Bio BOLD|Exicure, Inc. (XCUR) - Book Price of a Share|Accounting Value per Share imunon.com|Phio Pharmaceuticals Corp. (PHIO) - Equity per Share|Mustang Bio Inc - Book Value per Share|Book Value of One Share TransCode|Book Value per Share Bionano Genomics, Inc. BNGO|Equity per Share APDN (Applied DNA Sciences Inc)|BLUE - Net Assets per Single Share|Equity per Share ImmunoPrecise Antibodies Ltd IPA|Omega Therapeutics - Book Value per Share|OMIC - Book Value per Share|RGLS - Book Value per Share|Book Price of a Share Syros Pharmaceuticals Inc.|Accounting Value per Share Codex DNA (TBIO)|Equity per Share TRACON Pharmaceuticals, Inc (TCON)|Unity Biotechnology (UBX) - Accounting Value per Share